Previous 10 | Next 10 |
ESSA Pharma (EPIX) has entered into a clinical collaboration and supply agreement with Johnson & Johnson's (JNJ) company Janssen, to evaluate two combination with Essa's androgen receptor inhibitor EPI-7386 in patients with metastatic castration-resistant prostate cancer ((mCRPC...
ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castration-Resistant Prostate Cancer PR Newswire HOUSTON and VANCOUVER, BC , Jan. 13, 2021 /PRNewswire/ - ESSA Pharma Inc. (Nasdaq: EPI...
ESSA Pharma (EPIX): FQ4 GAAP EPS of -$0.17 beats by $0.02. Cash reserves and short-term investments of $~78.33M.Press Release For further details see: ESSA Pharma EPS beats by $0.02
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2020 VANCOUVER and HOUSTON , Dec. 15, 2020 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage phar...
ESSA Pharma to Participate at Evercore ISI 3rd Annual HealthCONx Conference PR Newswire HOUSTON and VANCOUVER, BC, Nov. 25, 2020 HOUSTON and VANCOUVER, BC , Nov. 25, 2020 /PRNewswire/ - ESSA Pharma Inc. (Nasdaq: EPIX) ("ESSA" or the "Company"), a clin...
ESSA Pharma to Participate in Upcoming Investor Conferences Canada NewsWire HOUSTON and VANCOUVER, BC, Nov. 10, 2020 HOUSTON and VANCOUVER, BC , Nov. 10, 2020 /CNW/ - ESSA Pharma Inc. (Nasdaq: EPIX) ("ESSA" or the "Company"), a clinical-stage pharmace...
ESSA Pharma (EPIX) has announced its intention to voluntarily delist from the TSX Venture Exchange, which is currently anticipated to occur on October 30, and continue trading on NASDAQ.Press Release For further details see: ESSA Pharma to delist from from TSX-V
ESSA Pharma Inc. Announces Delisting from the TSX-V Canada NewsWire HOUSTON and VANCOUVER, BC, Oct. 26, 2020 HOUSTON and VANCOUVER, BC , Oct. 26, 2020 /CNW/ - ESSA Pharma Inc. (" ESSA " or the " Company ") (TSX-V: EPI) (NASDAQ: EPIX), a clinical s...
ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR Symposium PR Newswire HOUSTON and VANCOUVER, BC, Oct. 24, 2020 HOUSTON and VANCOUVER, BC , Oct. 24, 2020 /PRNewswire/ - ESSA Pharma Inc. (Nasdaq: EPIX) (TSXV: EPI), a clini...
ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & MedTech Summit ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & MedTech Summit PR Newswire HOUSTON and VANCOUVER, BC, Sept. 21, 2020 HOUSTON and VANCOUV...
News, Short Squeeze, Breakout and More Instantly...
ESSA Pharma to Present at the JonesHealthcare Seaside Summit Canada NewsWire SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC , July 8, 2024 /CNW/ - ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on de...
ESSA Pharma to Present at the Jefferies Global Healthcare Conference Canada NewsWire SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC , May 30, 2024 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focus...